Andere Sprachen Numinus Wellness Inc.

Aktien

A2P4XN

CA67054W1032

NUMI

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:47:55 30.04.2024			% 5 Tage	% 1. Jan.
0,075 ^CAD	-.--%		-11,76 %	-31,82 %

17.04.	Cybin wählt Cedar Clinical Research von Numinus Wellness Inc. als klinischen Forschungsstandort für seine Phase 3-Studie von CYB003	CI
15.04.	Transcript : Numinus Wellness Inc., Q2 2024 Earnings Call, Apr 15, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	17.04.
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003	17.04.
Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	17.04.
Numinus Wellness Drops 25% as it Explores Options for its Canadian Operations; FQ2 Profit Falls	15.04.
Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review	15.04.
Numinus Wellness Exploring Options For Canadian Operations; Comes After It Posted QoQ Decrease in Q2 Revenue, Gross Profit	15.04.
Numinus Wellness Brief: Co Has decided to Explore Opportunities to "Redefine, divest and/or discontinue" its Canadian clinical operations	15.04.
Numinus Wellness Brief: Says To Focus on U.S. operations and Citing "Strategic Adjustments" in its Canadian Market Presence	15.04.
Numinus Wellness Provides Corporate Update	15.04.
Numinus Wellness Provides Corporate Update	15.04.
Numinus Wellness Posts QoQ Decrease in Q2 Revenue, Gross Profit	15.04.
An undisclosed buyer agreed to acquire Canadian clinical operations from Numinus Wellness Inc..	15.04.
Numinus Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	13.04.
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13.04.
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13.04.
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024	09.04.
PharmAla Biotech Signs Sale Agreement with Numinus Wellness	26.03.
Numinus Wellness Submits Clinical Trial Application to Health Canada	20.03.
Numinus Wellness Brief: Says Submitted Clinical Trial Application	20.03.
Numinus Wellness Submits Clinical Trial Application	20.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Numinus Wellness Inc.

Aktien

A2P4XN

CA67054W1032

NUMI

Andere Sprachen

Filter